Long-term outcomes among adults with Langerhans cell histiocytosis

Advances in the treatment of Langerhans cell histiocytosis (LCH) have resulted in a growing survivor population. There is a lack of data on long-term outcomes among adults with LCH. We conducted a retrospective record review of 219 adults (aged ≥18 years) with LCH. Most common presentation was multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Goyal, Gaurav, Acosta-Medina, Aldo A., Abeykoon, Jithma P., Dai, Chen, Ravindran, Aishwarya, Vassallo, Robert, Ryu, Jay H., Shah, Mithun V., Bennani, N. Nora, Young, Jason R., Bach, Corrie R., Ruan, Gordon J., Zanwar, Saurabh, Tobin, W. Oliver, Koster, Matthew J., Davidge-Pitts, Caroline J., Gruber, Lucinda M., Dasari, Surendra, Rech, Karen L., Go, Ronald S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Myeloid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641096/
https://www.ncbi.nlm.nih.gov/pubmed/37698994
http://dx.doi.org/10.1182/bloodadvances.2023010706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641096/
https://www.ncbi.nlm.nih.gov/pubmed/37698994
http://dx.doi.org/10.1182/bloodadvances.2023010706

Ejemplares similares